12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Genmab preclinical data

In xenograft models of human bladder, lung, pancreas, prostate, ovarian and cervical cancers, HuMax-TF-ADC led to complete tumor...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >